3,751
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections

, , , &
Pages 1193-1200 | Received 31 May 2017, Accepted 27 Sep 2017, Published online: 14 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiangyi Cui, Yuhong Lü & Changwu Yue. (2021) Development and Research Progress of Anti-Drug Resistant Bacteria Drugs. Infection and Drug Resistance 14, pages 5575-5593.
Read now

Articles from other publishers (15)

Adrien Turban, François Guérin, Aurélien Dinh & Vincent Cattoir. (2023) Updated Review on Clinically-Relevant Properties of Delafloxacin. Antibiotics 12:8, pages 1241.
Crossref
Eric Farfour, Louise Ruffier d'Epenoux, Anaëlle Muggeo, Corentine Alauzet, Lise Crémet, Sophie Moussalih, Antoine Roux, Sylvie C de Verdière, Amélie Bosphore, Stéphane Corvec, Thomas Guillard & Marc Vasse. (2023) In vitro susceptibility of nonfermenting Gram-negative rods to meropenem–vaborbactam and delafloxacin . Future Microbiology 18:2, pages 117-126.
Crossref
L. J. Scott. (2020) Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. Drugs 80:12, pages 1247-1258.
Crossref
. (2019) Newer Antibiotics: Need for More Studies in Neonates and Children. Pediatric Infectious Disease 1:4, pages 164-168.
Crossref
Prawez Alam, Essam Ezzeldin, Muzaffar Iqbal, Gamal A.E. Mostafa, Md. Khalid Anwer, Mohammed H. Alqarni, Ahmed I. Foudah & Faiyaz Shakeel. (2020) Determination of Delafloxacin in Pharmaceutical Formulations Using a Green RP-HPTLC and NP-HPTLC Methods: A Comparative Study. Antibiotics 9:6, pages 359.
Crossref
Md. Khalid Anwer, Muqtader Mohammad, Nasr Y. Khalil, Faisal Imam, Mohammad Javed Ansari, Mohammed F. Aldawsari, Faiyaz Shakeel & Muzaffar Iqbal. (2020) Solubility, thermodynamics and molecular interaction studies of delafloxacin in environmental friendly ionic liquids. Journal of Molecular Liquids 305, pages 112854.
Crossref
Prawez Alam, Muzaffar Iqbal, Essam Ezzeldin, Nasr Y. Khalil, Ahmed I. Foudah, Mohammed H. Alqarni & Faiyaz Shakeel. (2020) Simple and Accurate HPTLC-Densitometric Method for Quantification of Delafloxacin (A Novel Fluoroquinolone Antibiotic) in Plasma Samples: Application to Pharmacokinetic Study in Rats. Antibiotics 9:3, pages 134.
Crossref
Md. Khalid Anwer, Muzaffar Iqbal, Magdy M. Muharram, Muqtader Mohammad, Essam Ezzeldin, Mohammed F. Aldawsari, Ahmed Alalaiwe & Faisal Imam. (2020) Development of Lipomer Nanoparticles for the Enhancement of Drug Release, Anti-Microbial Activity and Bioavailability of Delafloxacin. Pharmaceutics 12:3, pages 252.
Crossref
Muzaffar Iqbal, Essam Ezzeldin, Rashed Naji Herqash, Md. Khalid Anwer & Faizul Azam. (2020) Development and validation of a novel UPLC-MS/MS method for quantification of delafloxacin in plasma and aqueous humour for pharmacokinetic analyses. Journal of Chromatography B 1138, pages 121961.
Crossref
Ramkrushna Ashok Salunke, Manjulika Shukla, Grace Kaul, Baldev Raj Bansal, Sidharth Chopra & Manmohan Chhibber. (2019) New fluoroquinolone compounds with endo ‐nortropine derivatives at C‐7 position show antibacterial activity against fluoroquinolone‐resistant strains of Staphylococcus aureus . Chemical Biology & Drug Design 94:3, pages 1626-1633.
Crossref
Jennifer Shiu, Grace Ting & Tony KL Kiang. (2018) Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin. European Journal of Drug Metabolism and Pharmacokinetics 44:3, pages 305-317.
Crossref
Matteo Bassetti, David Hooper & Glenn Tillotson. (2019) Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases 68:Supplement_3, pages S233-S240.
Crossref
Paul M Tulkens, Françoise Van Bambeke & Stephen H Zinner. (2019) Profile of a Novel Anionic Fluoroquinolone—Delafloxacin. Clinical Infectious Diseases 68:Supplement_3, pages S213-S222.
Crossref
忠秋 郭. (2019) Delafloxacin: A Novel Fluoroquinolones Broad-Spectrum Antibacterial. Pharmacy Information 08:01, pages 9-15.
Crossref
Matteo Bassetti, Elda Righi, Davide Pecori & Glenn Tillotson. (2018) Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering. Future Microbiology 13:10, pages 1081-1094.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.